MediLavia
Mon–Sat 08:00–20:00
All articles
MediLavia Center for General Medicine, Laboratory and Instrumental Diagnostics
July 13, 202612 min read

MediLavia Center for General Medicine, Laboratory and Instrumental Diagnostics

Health starts with accurate navigation. At MediLavia, preventive and lifestyle medicine are the foundation of the clinic: we assess not only complaints but also risks, habits, family history and the patient’s long-term goals. We do not do check-ups as a formality and do not limit ourselves to the tests available at the clinic; if a test needs to be done elsewhere, we will tell you and arrange the right referral. The general practitioner coordinates the patient’s entire pathway and makes sure the examination is truly complete, personalized and matched to your particular risks.

How thinking about preventive check-ups has changed

Traditional “general check-ups” — mass screening with a fixed set of tests for everyone — were long considered the gold standard of preventive medicine. However, a Cochrane systematic review (Krogsboll et al., 2019) [1], which analyzed 17 randomized controlled trials with more than 251,000 patients, showed that general check-ups do not reduce overall mortality (RR 1.00, 95% CI 0.97–1.03) and do not reduce cardiovascular mortality (RR 1.00, 95% CI 0.95–1.06). This means the “test everything for everyone” approach does not work.

However, this does not mean that prevention is useless. On the contrary, personalized examinations based on individual risk factors are considerably more effective. The recommendations of the USPSTF (U.S. Preventive Services Task Force) [2] stress that screening should be risk-stratified: its scope and frequency depend on age, sex, family history, lifestyle and — especially important in 2026 — the patient’s genetic profile.

Genetics as a revolution in preventive medicine

The development of genomic medicine has fundamentally changed the approach to check-ups. A study published in Genetics in Medicine (Buchanan et al., 2024) [3] showed that population genomic screening finds clinically significant mutations in 3.5% of those tested, and more than 90% of them had no family history of the disease. Without genetic testing, these patients would only have learned of their risk after the disease appeared.

Genomics-informed preventive medicine [4] makes it possible to move from a reactive approach (“we treat the disease”) to a proactive one (“we manage the risks”). The genetic profile determines exactly which tests a particular patient needs, how often and by which methods.

MediLavia’s position: we do not do “box-ticking” health checks. We create a personalized risk map based on your genetic profile, family history and lifestyle — and build an examination program that protects you specifically.

A practical case: managing a patient with a BRCA1 mutation

Patient A., 38, came to the clinic for a check-up. Family history: her mother had breast cancer at 52.

  • Step 1. Genetic testing (LabQuest)a panel for hereditary cancer syndromes. Result: a pathogenic mutation in the BRCA1 gene (c.5266dupC) was found. Cumulative risk of breast cancer by age 70 — up to 72%, ovarian cancer — up to 44% [5]
  • Step 2. Consultation with a geneticistexplaining the results, assessing the risks, recommendations on testing first-degree relatives
  • Step 3. An individual follow-up program (GP + gynecologist)a personal examination schedule (see the table below)
TestFrequencyMethod
Breast MRI with contrastEvery 6 monthsAlternating with mammography
MammographyEvery 6 monthsAlternating with MRI
Breast ultrasound (LOGIQ P9)Every 6 monthsIn addition to MRI/mammography
CA-125 tumor markerEvery 6 monthsLabQuest laboratory
Transvaginal ultrasound (LOGIQ P9)Every 6 monthsOvarian assessment
Gynecological examinationEvery 6 monthsExpert consultation
Consultation with a breast oncologistAnnuallyOn referral from the GP
  • Step 4. Discussing prevention strategiesinformation about risk-reducing surgery (prophylactic mastectomy, salpingo-oophorectomy) and medical prevention (tamoxifen, aromatase inhibitors) — with referral to specialists at federal centers
  • Step 5. Long-term follow-upthe GP coordinates all visits, keeps track of examination dates and ensures continuity between specialists

The takeaway for the patient: without genetic testing, patient A. would have had a standard mammogram every 2 years (as recommended for the general population). Given her BRCA1 mutation, she receives a follow-up program that is four times more intensive — and that is exactly what may save her life.

Expert imaging with AI support

MediLavia is equipped with the Genoray PAPAYA 3D Premium cone beam CT scanner (South Korea), an expert-class device designed for high-precision 3D imaging of the maxillofacial region.

ParameterValue
ManufacturerGenoray Co., Ltd. (South Korea)
ModelPAPAYA 3D Premium
Fields of view (FOV)From 5×5 cm (a single tooth) to 16×18 cm (the entire maxillofacial region, including the sinuses and ENT area)
Resolution (voxel size)From 80 µm — ultra-high resolution for endodontics and implantology
Scan timeFrom 9 seconds — minimal exposure
Effective doseFrom 24 µSv (minimum FOV) — comparable to 2–3 periapical X-rays
Registration certificateNo. RZN 2019/8559 of July 26, 2019 (Roszdravnadzor)

Use in dentistry. The PAPAYA 3D Premium CBCT provides the three-dimensional imaging needed for planning implant treatment (assessing bone volume and density), endodontic treatment (finding additional canals, root fractures), orthodontic diagnosis (position of impacted teeth) and surgical planning (wisdom tooth removal, root-end resection).

Use in ENT practice. Thanks to its extended field of view (up to 16×18 cm), the device shows all the paranasal sinuses, the nasal septum, the temporal bones and the upper airway. This is critical for diagnosing chronic sinusitis, polyps and maxillary sinus cysts, and for planning sinus lifts as part of the multidisciplinary “ENT + dentist” approach.

Diagnocat artificial intelligence: a second opinion for every scan

All CBCT scans at MediLavia are automatically analyzed by Diagnocat, a leading AI system for dental diagnostics, cleared by the FDA (October 2025) [6] and developed with the participation of 55 leading dentists and radiologists from around the world.

Diagnocat featureDescription
Radiology report (3D)Automatic detection of more than 60 conditions for each tooth
Radiology report (2D)Analysis of panoramic and periapical X-rays — more than 40 conditions
3D modelingAutomatic segmentation of DICOM into STL models for surgical planning
Implant reportAssessment of bone and distances to nerves and sinuses
Orthodontic reportCephalometric analysis and assessment of tooth position

A study published in a peer-reviewed journal (Ezhov M. et al.) [7] confirmed that Diagnocat shows excellent accuracy in detecting dental conditions on CBCT scans. Its accuracy is 96% for endodontically treated teeth, 100% for impactions and 100% for fillings [6].

How this works for a MediLavia patient: your scan is analyzed by two experts — a doctor and artificial intelligence. The AI will not miss a hidden problem, and the doctor makes the final decision based on your clinical picture. It is a triple check: technology, AI and the doctor’s expertise.

Radiation safety: facts, not promises

FactEvidence
Minimal radiation doseAn effective dose from 24 µSv (PAPAYA 3D) is less than 1% of the annual permissible limit (1,000 µSv for the general public)
Individual monitoringThe effective radiation dose is calculated for each patient and recorded in the medical record
ALARA principleAll examinations follow the principle of “as low as reasonably achievable”
Justified referralsEvery CT scan is ordered only when clinically indicated — the doctor justifies the need
Patient protectionLead aprons, thyroid collars, control of the scan area
Pediatric protocolReduced exposure settings and the minimum field of view are used for children

Responsible for radiation safety and the introduction of AI methods in imaging: Deputy Chief Medical Officer for Dentistry A.S. Garusov.

Expert-class ultrasound: GE LOGIQ P9 XDclear

MediLavia is equipped with the expert-class GE LOGIQ P9 XDclear ultrasound system (GE HealthCare, USA), a versatile platform for diagnosing adults and children.

ParameterValue
ManufacturerGE HealthCare (USA)
ModelLOGIQ P9 XDclear
Probe technologyXDclear — high-frequency broadband probes for maximum resolution
AI toolsAuto IMT, AutoEF, Measure Assistant, Compare Assistant, Scan Assistant
Elastography2D Shear Wave Elastography
CybersecuritySonoDefense — multi-level protection of patient data
ApplicationsAbdominal, breast, liver, pediatrics, urology, vascular

Ultrasound for adults. 2D Shear Wave Elastography makes it possible to assess the stiffness of the liver (staging fibrosis without a biopsy), thyroid and breast tissue non-invasively. The built-in Auto IMT algorithm automatically measures the intima-media thickness of the carotid arteries, a key marker of atherosclerosis and cardiovascular risk. The AutoEF function calculates the left ventricular ejection fraction automatically, which is critical for cardiac screening.

Ultrasound for children. Ultrasound is the ideal method for pediatrics because it uses no ionizing radiation and is completely safe for children of any age, including newborns. The GE LOGIQ P9 XDclear has specialized high-frequency pediatric probes that show a child’s small anatomical structures in exceptional detail. The system automatically adapts the scan settings to the patient’s size, which ensures optimal image quality without extra adjustments. This is especially important when examining restless children, when the speed of the examination is crucial.

Laboratory diagnostics and genetics

Our partnership with LabQuest provides the full range of laboratory tests — from a complete blood count to molecular genetic panels. Genetic tests can reveal a predisposition to cancer, cardiovascular and hereditary diseases long before they appear.

Functional diagnostics

Functional tests show not the structure but the work of organs and systems in real time. This is critical for detecting hidden disorders that are not visible on ultrasound or in blood tests:

  • ECG (at rest and with exercise)
  • Holter ECG monitoring (24/48 hours)
  • ABPM — 24-hour ambulatory blood pressure monitoring
  • Spirometry — assessment of lung function
  • H. pylori breath test

Expert gynecology and urology

At MediLavia, the gynecologist and urologist are not just check-up doctors. They are experts in minimally invasive endoscopic surgery and in reconstructive, plastic and aesthetic techniques.

  • Gynecologycheck-ups, endoscopic surgery, reconstructive and plastic surgery
  • Aesthetic gynecologyPRP therapy, hyaluronic acid fillers, thread lifting
  • Urologyexpert consultations, men’s check-ups, minimally invasive procedures

Check-up programs

Personalized examination programs are an investment in the future. The programs are indicative; the final content is approved only by the GP.

ProgramWho it is forKey testsDuration
Executive Check-up (M/F)Busy professionals aged 30–60Ultrasound of all organs, laboratory tests, ECG, consultations1–2 days
Cancer screening + GeneticsPatients with a family historyGenetic panels, tumor markers, ultrasound, consultation with a geneticist2–3 days
Children’s “Safe Start”Children aged 0–17Ultrasound (LOGIQ P9), laboratory tests, examination by a pediatrician1 day
“Aesthetics and Health 45+”Women 45+Gynecology, endocrinology, ultrasound, genetics of aging, bone densitometry2 days
“A Leader’s Healthy Heart”Men 40+ECG, Holter, ABPM, echocardiography, Doppler ultrasound of the brachiocephalic arteries, laboratory tests1–2 days

Everything listed above — the GP, ultrasound, laboratory, urologist and gynecologist — works as a single system. The Center for General Medicine provides a holistic view of health, a personalized choice of tests, honest navigation across all of medicine and long-term support for the patient, rather than a one-off box-ticking check-up.

Sources

  1. 1.Krogsboll L.T., Jorgensen K.J., Gotzsche P.C. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews, 2019.
  2. 2.U.S. Preventive Services Task Force (USPSTF). Recommendations for Primary Care Practice.
  3. 3.Buchanan A.H. et al. Population genomic screening: findings from a large-scale study. Genetics in Medicine, 2024.
  4. 4.Manolio T.A. et al. Genomics-Informed Preventive Medicine. PMC, 2025.
  5. 5.Kuchenbaecker K.B. et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA, 2017; 317(23): 2402–2416.
  6. 6.Diagnocat. Official website. AI Diagnostic Dental Solutions.
  7. 7.Ezhov M., Gusarev M. et al. Clinically applicable artificial intelligence system for dental diagnosis with CBCT. Scientific Reports, Nature.

Still have questions?

Book a consultation with a specialist

Book